Literature DB >> 19641900

A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia.

Michelle Y Deng1, Gráinne M McAlonan, Charlton Cheung, Cindy P Y Chiu, Chi W Law, Vinci Cheung, Pak C Sham, Eric Y H Chen, Siew E Chua.   

Abstract

BACKGROUND: Anti-psychotic treatment appears to be associated with striatal volume increase, but how early this change occurs is still unknown.
METHODS: A single prospective cohort of 20 anti-psychotic-naïve patients, newly diagnosed with schizophrenia, underwent magnetic resonance imaging brain scan at baseline. This was repeated following up to 8 weeks of anti-psychotic treatment. Ten patients had repeat scan within only 3 weeks. The choice of anti-psychotic medication was naturalistic, i.e., clinician-led. Well-matched healthy individuals were also scanned to control for non-specific changes over a 3-week period.
RESULTS: After 3 weeks of anti-psychotic treatment, significant grey matter volume increase in the right caudate, superior and inferior frontal gyrus, precentral gyrus, and left inferior parietal lobule was noted. However, after 8 weeks of anti-psychotic treatment, volume increase in the right thalamus and bilateral cerebellum was observed. Significant grey matter reduction was detected in the left medial frontal gyrus at both 3- and 8-week intervals.
CONCLUSIONS: Early increase in striatal volume change occurs as early as 3 weeks after anti-psychotic treatment, whilst thalamic volume increase is apparent later, by 8 weeks of treatment. We speculate that drug-mediated neuroplasticity may provide a biomarker for clinical recovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641900     DOI: 10.1007/s00213-009-1619-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Authors:  M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

2.  Inhibition of DNA repair synthesis in the rat by in vivo exposure to psychotropic drugs and reversal of the effect by co-administration with alpha-tocopherol.

Authors:  R J Srám; B Binková; J Topinka; I Fojtíková
Journal:  Mutat Res       Date:  1990-08       Impact factor: 2.433

Review 3.  Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.

Authors:  H Y Meltzer; P A Thompson; M A Lee; R Ranjan
Journal:  Neuropsychopharmacology       Date:  1996-03       Impact factor: 7.853

4.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Authors:  R S Keefe; S G Silva; D O Perkins; J A Lieberman
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

5.  Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat.

Authors:  Hui-Dong Wang; Floyd D Dunnavant; Tabitha Jarman; Ariel Y Deutch
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

6.  Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?

Authors:  Philip J Tyson; Kate H Roberts; Ann M Mortimer
Journal:  Int J Neurosci       Date:  2004-06       Impact factor: 2.292

Review 7.  Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.

Authors:  P O'Donnell; A A Grace
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia.

Authors:  Gaku Okugawa; Kenji Nobuhara; Katsunori Takase; Yukiko Saito; Masafumi Yoshimura; Toshihiko Kinoshita
Journal:  Neuropsychobiology       Date:  2007-06-08       Impact factor: 2.328

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  29 in total

1.  Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry.

Authors:  Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-28       Impact factor: 5.270

Review 2.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

3.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.

Authors:  M Mallar Chakravarty; Judith L Rapoport; Jay N Giedd; Armin Raznahan; Philip Shaw; D Louis Collins; Jason P Lerch; Nitin Gogtay
Journal:  Hum Brain Mapp       Date:  2014-12-11       Impact factor: 5.038

4.  Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus.

Authors:  Tomas Hajek; Jeffrey Cullis; Tomas Novak; Miloslav Kopecek; Ryan Blagdon; Lukas Propper; Pavla Stopkova; Anne Duffy; Cyril Hoschl; Rudolf Uher; Tomas Paus; L Trevor Young; Martin Alda
Journal:  Biol Psychiatry       Date:  2012-07-20       Impact factor: 13.382

5.  A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia.

Authors:  Eric A Nelson; Nina V Kraguljac; David M White; Ripu D Jindal; Ah L Shin; Adrienne C Lahti
Journal:  Can J Psychiatry       Date:  2020-02-05       Impact factor: 4.356

6.  Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.

Authors:  Miran Kenk; Thiviya Selvanathan; Naren Rao; Ivonne Suridjan; Pablo Rusjan; Gary Remington; Jeffrey H Meyer; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

7.  Reduced mediodorsal thalamic volume and prefrontal cortical spindle activity in schizophrenia.

Authors:  Andreas Buchmann; Daniela Dentico; Michael J Peterson; Brady A Riedner; Simone Sarasso; Marcello Massimini; Giulio Tononi; Fabio Ferrarelli
Journal:  Neuroimage       Date:  2014-08-17       Impact factor: 6.556

8.  Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.

Authors:  Kevin Yu; Charlton Cheung; Meikei Leung; Qi Li; Siew Chua; Gráinne McAlonan
Journal:  Front Hum Neurosci       Date:  2010-10-26       Impact factor: 3.169

9.  Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.

Authors:  Meikei Leung; Charlton Cheung; Kevin Yu; Benjamin Yip; Pak Sham; Qi Li; Siew Chua; Grainne McAlonan
Journal:  Schizophr Bull       Date:  2009-09-16       Impact factor: 9.306

10.  Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis.

Authors:  Xin Gao; Wenjing Zhang; Li Yao; Yuan Xiao; Lu Liu; Jieke Liu; Siyi Li; Bo Tao; Chandan Shah; Qiyong Gong; John A Sweeney; Su Lui
Journal:  J Psychiatry Neurosci       Date:  2018-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.